Travere Therapeutics, Inc. SEC filings TVTX

Travere Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Travere Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 15, 2026 —
8-K Current report
Officer or director change
Sep 21, 2026 Sep 21, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 11, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 10, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Officer or director change
Jul 9, 2026 Jul 6, 2026
4 Insider transaction Jun 22, 2026 Jun 22, 2026
S-8 Employee stock plan registration Jun 17, 2026 —
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
8-K Current report
Officer or director change
Jun 16, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
8-K Current report
Material agreement
Jun 2, 2026 Jun 1, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
4 Insider transaction May 21, 2026 May 19, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 15, 2026
144 Notice of proposed sale May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 11, 2026 May 6, 2026
424B5 Prospectus supplement May 7, 2026 —
305B2 Filing May 7, 2026 —
FWP Free writing prospectus May 7, 2026 —
4 Insider transaction May 6, 2026 May 5, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 5, 2026 —
424B5 Prospectus supplement May 5, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
4 Insider transaction May 4, 2026 May 1, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
4 Insider transaction Apr 23, 2026 Apr 22, 2026
144 Notice of proposed sale Apr 22, 2026 —
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
4 Insider transaction Apr 15, 2026 Apr 13, 2026
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
8-K Current report
Other events
Apr 14, 2026 Apr 13, 2026
144 Notice of proposed sale Apr 13, 2026 —
4 Insider transaction Apr 7, 2026 Apr 6, 2026
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 May 19, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 18, 2026 Mar 16, 2026
144 Notice of proposed sale Mar 16, 2026 —
4 Insider transaction Feb 24, 2026 Feb 20, 2026
144 Notice of proposed sale Feb 20, 2026 —
10-K Annual report Feb 19, 2026 Dec 31, 2025
4 Insider transaction Feb 19, 2026 Feb 17, 2026
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Feb 5, 2026 Feb 4, 2026
4 Insider transaction Feb 5, 2026 Feb 4, 2026
4 Insider transaction Feb 5, 2026 Feb 4, 2026
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
144 Notice of proposed sale Feb 3, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Jan 27, 2026 Jan 23, 2026
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 23, 2026 —
4 Insider transaction Jan 21, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
8-K Current report
Other events
Jan 13, 2026 Jan 13, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 16, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
144 Notice of proposed sale Nov 4, 2025 —
4 Insider transaction Nov 4, 2025 Oct 31, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
144 Notice of proposed sale Oct 31, 2025 —
144 Notice of proposed sale Oct 31, 2025 —
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
144 Notice of proposed sale Oct 29, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 14, 2025 —
4 Insider transaction Sep 24, 2025 Sep 23, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 22, 2025 —
8-K Current report
Other events
Sep 10, 2025 Sep 10, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TVTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1438533
Former names
Retrophin, Inc. (until Nov 13, 2020); Desert Gateway, Inc. (until Feb 19, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.